Literature DB >> 4027383

Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males.

S P Kalter, S A Riggs, F Cabanillas, J J Butler, F B Hagemeister, P W Mansell, G R Newell, W S Velasquez, P Salvador, B Barlogie.   

Abstract

During the period from 1981 through 1984, 14 immunocompromised homosexual males with intermediate or high-grade non-Hodgkin's lymphoma were seen at University of Texas M.D. Anderson Hospital and Tumor Institute. Six patients had diffuse large-cell lymphoma, seven had diffuse undifferentiated lymphoma, and one had unclassifiable lymphoma that suggested large-cell lymphoma. Eight patients had the acquired immunodeficiency syndrome (AIDS) and five had the AIDS-related complex. Kaposi's sarcoma was initially present in four patients and developed later in two others. The patients with diffuse large-cell lymphoma were characterized by more severely altered immune parameters, multicentric brain mass lesions, pretherapy opportunistic infections, lower performance status, poor response to therapy, and death in all within six months. The undifferentiated lymphoma group had preceding generalized reactive lymphadenopathy, less severe immune dysfunction, and excellent response to combination chemotherapy, with survival time greater than 19 months in three patients. Twelve of the patients had extranodal sites of lymphoma at presentation. There is a definite trend for the development of aggressive non-Hodgkin's lymphomas with unusual sites of extranodal involvement in immunocompromised homosexual males, with the potential for good tolerance to combination chemotherapy and improved survival in the subgroup without severe concomitant opportunistic infections.

Entities:  

Mesh:

Year:  1985        PMID: 4027383

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.

Authors:  B Borisch-Chappuis; C Nezelof; H Müller; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

Review 2.  Treating Burkitt Lymphoma in Adults.

Authors:  Carla Casulo; Jonathan Friedberg
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

3.  AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.

Authors:  S J Hamilton-Dutoit; G Pallesen; M B Franzmann; J Karkov; F Black; P Skinhøj; C Pedersen
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

4.  Non-Hodgkin lymphomas of the central nervous system.

Authors:  F Pisani; M Antimi; M Cantonetti; M G Marciani; M Masi; M Tribalto; G Papa
Journal:  Ital J Neurol Sci       Date:  1991-10

5.  HIV-related malignant lymphomas. A clinical and pathological study of 13 cases.

Authors:  M Serke; D Huhn; D Dienemann; D Eichenlaub; S Sterke; H Stein
Journal:  Klin Wochenschr       Date:  1988-08-01

6.  Update on the Pathogenesis, Diagnosis, and Therapy of AIDS-related Lymphoma.

Authors:  Richard F. Little; Wyndham H. Wilson
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.663

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.